Concurrent emphysematous cholecystitis and emphysematous cystitis in a non-diabetic patient.
Emphysematous cholecystitis and emphysematous cystitis occurring concurrently has not been reported before. This article discusses a non-diabetic patient suffering from both these conditions concurrently with Escherichia coli as the causative organism - a first in the medical literature.
Ayoub
Tariq
T
Central Middlesex Hospital, Northwest London Hospital NHS Trust, London.
Arshad
Ilyas
I
Donnellan
Imelda
I
D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D003556:Cystitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D004359:Drug Therapy, Combination; D004646:Emphysema / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D041882:Emphysematous Cholecystitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology; D004927:Escherichia coli Infections / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D008795:Metronidazole; D002444:Cefuroxime